Studying liver fats and proteins in adults with fatty liver disease
Examines which liver fats and proteins are linked to fatty liver disease severity.
Key facts
- Who runs it
- Vanderbilt University
- Where
- Nashville, United StatesSee the site
- Trial code
- Registry title
- Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
- Status
- Enrolling by invitation
- People taking part
- 45 people, planned
- Started
- Oct 2009
- Expected to end
- Nov 2026
- Type of study
- Observational, 3 groups
- Record updated
- 18 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 65 who are having planned abdominal or weight-loss surgery. It studies fats and proteins linked to fatty liver disease.
- Age
- 18 to 65 years
- Sex
- Women only
- Disease stage
- Not specified. Liver enzyme levels (ALT/AST) may be normal or raised.
- Earlier treatment
- People who use any thiazolidinediones cannot join.
Main reasons for not taking part
- Viral hepatitis
- Significant alcohol use
- Current infections
- Use of any thiazolidinediones
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- 18-65 year of age
- Undergoing elective abdominal or bariatric surgery
- May have normal or elevated ALT/AST levels
Who cannot take part
- Presence of viral hepatitis
- Intercurrent infections
- Significant alcohol use
- Use of any thiazolidinediones
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- Vanderbilt University Medical CenterNashville, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Nonalcoholic fatty liver disease (NAFLD) is the most common type of liver disease in the United States. The incidence of NAFLD is very similar to that of obesity, type 2 diabetes, and the metabolic syndrome. The investigators hypothesize that there may be a relationship between over-nutrition, decreased physical activity and the development of fatty liver. The purpose of this study is to identify the types of fats and proteins, and the quantity of each, that are associated with increased severity of NAFLD.
The 3 groups in the trial
- Obese, bariatric surgery, liver biopsy
Obese subjects approved and scheduled for bariatric surgery at Vanderbilt University Medical Center
- Normal BMI, abdominal surgery, liver biopsy
Normal weight subjects having elective abdominal surgery at Vanderbilt University Medical Center.
- Liver transplantation donors and recipients
All livers made available for implantation or explantation will be eligible.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Relative Abundance and Spatial Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
- Plain-language title
- Studying liver fats and proteins in adults with fatty liver diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT00983463, who can take part
- Record updated
- 18 December 2025